Patient
SITE007-0147
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE007 (JPN) (Dr. Dubois)
consented 2026-02-21
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
moderate
assessed
2026-08-06
Grade 2 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-30 (study day 149); relationship: NOT RELATED
moderate
assessed
2026-05-22
Grade 2 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-11-15 (study day 73); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.